Merge Technologies makes management moveConnectivity and PACS firm Merge Technologies has named Joseph Gentile director of worldwide system sales. Gentile will manage the Milwaukee, WI, firm’s systems solution group, which provides medical
Connectivity and PACS firm Merge Technologies has named Joseph Gentile director of worldwide system sales. Gentile will manage the Milwaukee, WI, firms systems solution group, which provides medical connectivity products and medical information appliances and servers. The company expects Gentiles experience as vice president of sales of IMACS Medical, which created a networked data and information management system for cardiology, to help it boost its business.
In other Merge news, the company last month began shipping its second-generation medical image information server MergeARK to facilities in Europe. MergeARK is part of the firms MergeWorks suite of products, and has been upgraded to improve its storage, retrieval, and reprint capacities. MergeARKs hardware and operating system software are now based on Dell servers and Red Hat Linux version 6.0, respectively. Some of Merges European installations of MergeARK will include DRM-7000, a CD-R library from Pioneer that can store 670 CDs to provide data storage of more than 400 gigabytes.
© 2000 Miller Freeman, Inc., a United News & Media company
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.